Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleSystemic Lupus Erythematosus

Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes

Stephen J. Balevic, Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg and Megan E.B. Clowse
The Journal of Rheumatology January 2019, 46 (1) 57-63; DOI: https://doi.org/10.3899/jrheum.180158
Stephen J. Balevic
From the departments of Internal Medicine and Pediatrics, Duke University, and Duke Clinical Research Institute, Durham, North Carolina; Department of Pediatrics, Children’s Hospital of Chicago, Chicago, Illinois, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen J. Balevic
  • For correspondence: Stephen.balevic@duke.edu
Michael Cohen-Wolkowiez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda M. Eudy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura E. Schanberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan E.B. Clowse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Clowse ME
    . Lupus activity in pregnancy. Rheum Dis Clin North Am 2007;33:237–52.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Peart E,
    2. Clowse ME
    . Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 2014;26:118–23.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Østensen M,
    2. Andreoli L,
    3. Brucato A,
    4. Cetin I,
    5. Chambers C,
    6. Clowse ME,
    7. et al.
    State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 2015;14:376–86.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Clowse ME
    . Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol 2010;24:373–85.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. de Man YA,
    2. Hazes JM,
    3. van der Heide H,
    4. Willemsen SP,
    5. de Groot CJ,
    6. Steegers EA,
    7. et al.
    Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009;60:3196–206.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Levy RA,
    2. Vilela VS,
    3. Cataldo MJ,
    4. Ramos RC,
    5. Duarte JL,
    6. Tura BR,
    7. et al.
    Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 2001;10:401–4.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Eudy AM,
    2. Siega-Riz AM,
    3. Engel SM,
    4. Franceschini N,
    5. Howard AG,
    6. Clowse ME,
    7. et al.
    Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis 2018;77:855–60.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Leroux M,
    2. Desveaux C,
    3. Parcevaux M,
    4. Julliac B,
    5. Gouyon JB,
    6. Dallay D,
    7. et al.
    Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus 2015;24:1384–91.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Costedoat-Chalumeau N,
    2. Amoura Z,
    3. Hulot JS,
    4. Hammoud HA,
    5. Aymard G,
    6. Cacoub P,
    7. et al.
    Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:3284–90.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Mok CC,
    2. Penn HJ,
    3. Chan KL,
    4. Tse SM,
    5. Langman LJ,
    6. Jannetto PJ
    . Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis. Arthritis Care Res 2016;68:1295–302.
    OpenUrl
  11. 11.↵
    1. Costedoat-Chalumeau N,
    2. Le Guern V,
    3. Piette JC
    . Routine hydroxychloroquine blood concentration measurement in systemic lupus erythematosus reaches adulthood [editorial]. J Rheumatol 2015;42:1997–9.
    OpenUrlFREE Full Text
  12. 12.↵
    1. Tett SE,
    2. Day RO,
    3. Cutler DJ
    . Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis—a cross sectional study. J Rheumatol 1993;20:1874–9.
    OpenUrlPubMed
  13. 13.↵
    1. Tett SE,
    2. Cutler DJ,
    3. Beck C,
    4. Day RO
    . Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis—a prospective, dose ranging study. J Rheumatol 2000;27:1656–60.
    OpenUrlPubMed
  14. 14.↵
    1. Costedoat-Chalumeau N,
    2. Amoura Z,
    3. Hulot JS,
    4. Aymard G,
    5. Leroux G,
    6. Marra D,
    7. et al.
    Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Ann Rheum Dis 2007;66:821–4.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Rainsford KD,
    2. Parke AL,
    3. Clifford-Rashotte M,
    4. Kean WF
    . Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 2015;23:231–69.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Jallouli M,
    2. Galicier L,
    3. Zahr N,
    4. Aumaitre O,
    5. Frances C,
    6. Le Guern V,
    7. et al;
    8. Plaquenil Lupus Systemic Study Group
    . Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis Rheumatol 2015;67:2176–84.
    OpenUrl
  17. 17.↵
    1. Ke AB,
    2. Rostami-Hodjegan A,
    3. Zhao P,
    4. Unadkat JD
    . Pharmacometrics in pregnancy: an unmet need. Annu Rev Pharmacol Toxicol 2014;54:53–69.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Buyon JP,
    2. Kalunian KC,
    3. Ramsey-Goldman R,
    4. Petri MA,
    5. Lockshin MD,
    6. Ruiz-Irastorza G,
    7. et al.
    Assessing disease activity in SLE patients during pregnancy. Lupus 1999;8:677–84.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Petri M,
    2. Howard D,
    3. Repke J,
    4. Goldman DW
    . The Hopkins Lupus Pregnancy Center: 1987–1991 update. Am J Reprod Immunol 1992;28:188–91.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Petri M,
    2. Howard D,
    3. Repke J
    . Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538–45.
    OpenUrlPubMed
  21. 21.↵
    1. Clowse ME,
    2. Magder LS,
    3. Witter F,
    4. Petri M
    . The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005;52:514–21.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Clowse ME,
    2. Magder L,
    3. Witter F,
    4. Petri M
    . Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006;54:3640–7.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Durcan L,
    2. Clarke WA,
    3. Magder LS,
    4. Petri M
    . Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence. J Rheumatol 2015;42:2092–7.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Costedoat-Chalumeau N,
    2. Houssiau F,
    3. Izmirly P,
    4. Le Guern V,
    5. Navarra S,
    6. Jolly M,
    7. et al.
    A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and self-administered questionnaires. Clin Pharmacol Ther 2018;103:1074–82.
    OpenUrl
  25. 25.↵
    1. Yeon Lee J,
    2. Lee J,
    3. Ki Kwok S,
    4. Hyeon Ju J,
    5. Su Park K,
    6. Park SH
    . Factors related to blood hydroxychloroquine concentration in patients with systemic lupus erythematosus. Arthritis Care Res 2017;69:536–42.
    OpenUrl
  26. 26.↵
    1. Iudici M,
    2. Pantano I,
    3. Fasano S,
    4. Pierro L,
    5. Charlier B,
    6. Pingeon M,
    7. et al.
    Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine nonadherence in systemic lupus patients with prolonged inactive disease. Lupus 2018;27:265–72.
    OpenUrl
  27. 27.↵
    1. Feldman CH,
    2. Yazdany J,
    3. Guan H,
    4. Solomon DH,
    5. Costenbader KH
    . Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res 2015;67:1712–21.
    OpenUrl
  28. 28.↵
    1. Mehat P,
    2. Atiquzzaman M,
    3. Esdaile JM,
    4. Aviña-Zubieta A,
    5. De Vera MA
    . Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res 2017;69:1706–13.
    OpenUrl
  29. 29.↵
    1. Costedoat-Chalumeau N,
    2. Galicier L,
    3. Aumaitre O,
    4. Frances C,
    5. Le Guern V,
    6. Liote F,
    7. et al;
    8. Group PLUS
    . Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann Rheum Dis 2013;72:1786–92.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Frances C,
    2. Cosnes A,
    3. Duhaut P,
    4. Zahr N,
    5. Soutou B,
    6. Ingen-Housz-Oro S,
    7. et al.
    Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. Arch Dermatol 2012;148:479–84.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Browning DJ
    . Pharmacology of chloroquine and hydroxychloroquine. In: Hydroxychloroquine and chloroquine retinopathy. New York: Springer-Verlag New York; 2014:35–63.
  32. 32.↵
    1. Hebert MF,
    2. Zheng S,
    3. Hays K,
    4. Shen DD,
    5. Davis CL,
    6. Umans JG,
    7. et al.
    Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 2013;95:908–15.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes
Stephen J. Balevic, Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, Megan E.B. Clowse
The Journal of Rheumatology Jan 2019, 46 (1) 57-63; DOI: 10.3899/jrheum.180158

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes
Stephen J. Balevic, Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, Megan E.B. Clowse
The Journal of Rheumatology Jan 2019, 46 (1) 57-63; DOI: 10.3899/jrheum.180158
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • APPENDIX 1.
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

SYSTEMIC LUPUS ERYTHEMATOSUS
HYDROXYCHLOROQUINE
PREGNANCY

Related Articles

Cited By...

More in this TOC Section

  • Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus
  • High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis
  • Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
Show more Systemic Lupus Erythematosus

Similar Articles

Keywords

  • systemic lupus erythematosus
  • hydroxychloroquine
  • pregnancy

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire